1-7 of 7
Carlos I. Amaya-Chanaga, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Sustained Responses Following Ibrutinib Discontinuation after Frontline Therapy with Obinutuzumab Plus Ibrutinib in Patients with Chronic Lymphocytic Leukemia

Paula A. Lengerke Diaz, MD, Michael Y. Choi, MD, Eider F. Moreno Cortes, MD, Jose V. Forero, MD, Juliana Velez-Lujan, PhD, Carlos I. Amaya-Chanaga, MD, Thomas Kipps, MDPhD, Januario E. Castro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-143473
Published: 2020
Journal Articles

Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) Combination for Patients with Chronic Lymphocytic Leukemia (CLL) - a Phase Ib/II Study

Januario E Castro, MD, Carlos I. Amaya-Chanaga, MD, Juliana Velez Lujan, BS,PhD, Michael Choi, MD, Colin McCarthy, BS, Thomas J. Kipps, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1730.
https://doi.org/10.1182/blood.V130.Suppl_1.1730.1730
Published: 2017
Journal Articles

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Carlos I. Amaya-Chanaga, MD, Michael Y. Choi, MD, Natalie Nguyen, B.Sc, Elizabeth DeVore, B.Sc, Colin MacCarthy, B.Sc, Jacqueline Hilger-Rolfe, PhD, M.S., Thomas J. Kipps, MD, PhD, Januario E. Castro, MD
Journal: Blood
Blood (2016) 128 (22): 2048.
https://doi.org/10.1182/blood.V128.22.2048.2048
Published: 2016
Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Colin MacCarthy, B.Sc, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 2051.
https://doi.org/10.1182/blood.V128.22.2051.2051
Published: 2016
Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Amine Ale-Ali, PharmD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4160.
https://doi.org/10.1182/blood.V126.23.4160.4160
Published: 2015
Journal Articles

Targeting the CXCR4-CXCL12 Pathway Using an Anti-CXCR4 IgG1 Antibody (PF-06747143) in Chronic Lymphocytic Leukemia

Manoj K. Kashyap, PhD, Carlos I. Amaya-Chanaga, MD, Deepak Kumar, PhD, Michael Y. Choi, MD, Laura Z. Rassenti, PhD, Amine Ale-Ali, PharmD, Shu-Hui Liu, PhD, Tod Smeal, Valeria Fantin, PhD, Thomas J. Kipps, MD, PhD, Flavia Pernasetti, Januario E. Castro, MD
Journal: Blood
Blood (2015) 126 (23): 4162.
https://doi.org/10.1182/blood.V126.23.4162.4162
Published: 2015
Journal Articles

BMS-936564 (Anti-CXCR4 Antibody) Induces Specific Leukemia Cell Mobilization and Objective Clinical Responses In CLL Patients Treated Under a Phase I Clinical Trial

Manoj Kumar Kashyap, PhD, Carlos I. Amaya-Chanaga, MD, Harrison Jones, BS, Eiman A. AlMahasnah, MBBS, Michael Y. Choi, MD, Michelle R. Kuhne, PhD, Lewis Cohen, MD, MS, Peter Sabbatini, PhD, Thomas J. Kipps, MD, PhD, Pina M. Cardarelli, Ph.D., Januario E. Castro, M.D.
Journal: Blood
Blood (2013) 122 (21): 4190.
https://doi.org/10.1182/blood.V122.21.4190.4190
Published: 2013